Welcome to our dedicated page for KT&G GDR 144A news (Ticker: KTCIY), a resource for investors and traders seeking the latest updates and insights on KT&G GDR 144A stock.
KT&G Corporation (KRX:033780), known for its tobacco, ginseng, and herbal products, has recently faced an ISS recommendation to vote against its Board of Directors' proposals. KT&G expressed concerns about ISS' reliance on data provided by dissident shareholder Flashlight Capital Partners, impacting overseas business performance analysis. Additionally, ISS' recommendations against CEO nominee Kyung-man Bang and other candidates raise questions on CEO selection impartiality and Board-endorsed Outside Candidate director candidacy. KT&G emphasizes rigorous CEO selection processes and inconsistencies between ISS' recommendations and its proxy voting guidelines. Furthermore, discussions between ISS, FCP, and KT&G raised concerns over export business profitability data discrepancies, misinformation, and interactions. KT&G seeks to engage constructively with stakeholders, address concerns, and ensure shareholder value.
The 13th International Symposium on Ginseng in Seoul highlighted significant research findings on the health benefits of ginseng. Key studies presented include:
- Red ginseng improves memory loss in PTSD and age-related cognitive decline.
- Ginsenoside Rd suppresses muscle atrophy and enhances muscle strength.
- Red ginseng prevents bone loss by maintaining intestinal microbiota.
- Ginseng reduces blood pressure in patients with diabetes and hypertension.
These findings position ginseng as a vital supplement for various health issues.
Flashlight Capital Partners, a significant shareholder of KT&G Corporation (KRX: 033780), urges for governance enhancements and a restructured board to increase shareholder value. The firm outlines a five-step plan aimed at closing a 50% trading discount, potentially unlocking 100% share price appreciation over the next 12 months. Key initiatives include spinning off the ginseng business, expanding the global reach of HNB products, divesting non-core assets, tripling share buybacks, and committing to actionable ESG improvements.
Korea Ginseng Corporation launches a new herbal drink line named HSW at the Natural Products Expo East, aiming to meet increasing demand for herbal beverages. The line features three caffeine-free flavors made from six-year-old Korean red ginseng and natural ingredients. The herbal beverage market is projected to grow to $2.45 billion by 2028. HSW's predecessor, HongSamWon, saw impressive revenue growth from $140K in 2015 to $8.23MM in 2021. The new drinks offer health benefits, including stress adaptation and improved mental focus.
Korea Ginseng Corporation has introduced Korean Red Ginseng as a leading adaptogen beneficial for golfers in enhancing performance and energy levels. The rise of golf popularity among the MZ Generation is evident, with 66.6 million golfers worldwide as of December 2021, marking a significant increase. Adaptogens promote overall health, reducing stress and fatigue. Rian Lee, CEO of KGC U.S., emphasizes their role in improving blood circulation and mental focus. KGC plans to feature their products during the Natural Products Expo East in Pennsylvania this September.
Korea Ginseng Corporation, the leading ginseng brand, shares practical tips for a healthier summer vacation. It highlights the benefits of Korean Red Ginseng, which include enhanced blood circulation, improved skin health, and natural energy boosts. A study from the University of Toronto confirms Korean Red Ginseng significantly improves blood flow. The company recently launched KORESELECT, a line of benefit-focused products aimed at addressing travel-related health challenges. CEO Rian Lee emphasizes the importance of health preparations for travelers.
The COVID-19 pandemic has transformed Family Month in Korea, shifting traditions to online gift-giving. Parents' Day, a key holiday, sees children prioritizing health gifts like red ginseng over cash. A recent survey revealed that about 60% of Millennials and Gen Z prefer health food gifts. Red ginseng, recognized for its immunity-boosting properties by the Ministry of Food and Drug Safety, dominates the market with CheongKwanJang holding 70% share. Sales of their products surged 70–80% in May, reflecting a growing focus on health amid the pandemic.
The Korea Society of Ginseng unveiled research indicating that red ginseng significantly alleviates fatigue and stress, notably post-COVID-19. The study, presented on April 21, 2022, highlighted that individuals recovering from coronavirus experienced prolonged fatigue. A controlled study involving 76 participants showed those consuming red ginseng reported less fatigue compared to a placebo. Another study confirmed its effectiveness in cancer patients undergoing chemotherapy. Additionally, antiviral properties against COVID-19 were noted, suggesting red ginseng could aid recovery from lingering symptoms.
Korea Ginseng Corporation (KGC), the world's leading ginseng brand, has launched its KORESELECT line in the U.S. market as of April 1, 2022. The KORESELECT products, made from six-year-grown red ginseng, aim to enhance health and wellness by promoting blood circulation, boosting stamina, and supporting immunity. The line features five product categories: Immune, Energy, Wellness, Balance, and Stamina, all free from GMOs and artificial additives. KGC, established in 1899, is renowned for its high-quality Korean Red Ginseng, recognized for its efficacy.
KGC (Korea Ginseng Corp.) has introduced the 'World Map of Red Ginseng', showcasing bestsellers by country from overseas sales in 2021. The stick-type product 'Everytime' topped sales in six Asian regions, including Japan. Global demand is rising, driven by health interests and K-drama influence. KGC's overseas sales increased by 4.8% in 2020 compared to 2019, with a 20% year-to-date rise in Q3 2021. The company is boosting online sales through e-commerce channels and aims to promote red ginseng worldwide.
FAQ
What recent recommendation did ISS make about KT&G Corporation's Board of Directors' proposals?
Why did KT&G Corporation express concerns about ISS' recommendation?
What were the concerns raised regarding ISS' recommendations against CEO nominee Kyung-man Bang and other candidates?
What issues were identified in the discussions between ISS, FCP, and KT&G Corporation?
How does KT&G Corporation plan to address the concerns and engage with stakeholders?
